Y-Intercept (HK)’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Buy
123,478
+67,886
+122% +$1.55M 0.05% 570
2026
Q1
$1.22M Sell
55,592
-146,771
-73% -$2.56M 0.02% 934
2025
Q4
$2.39M Buy
202,363
+68,267
+51% +$876K 0.05% 540
2025
Q3
$2.12M Buy
+134,096
New +$1.95M 0.05% 571
2025
Q1
Sell
-58,908
Closed -$996K 1235
2024
Q4
$996K Buy
+58,908
New +$1.15M 0.07% 429
2024
Q3
Sell
-40,997
Closed -$925K 1348
2024
Q2
$925K Sell
40,997
-26,389
-39% -$691K 0.05% 524
2024
Q1
$1.77M Buy
+67,386
New +$1.92M 0.13% 196
2023
Q4
Sell
-27,712
Closed -$777K 1265
2023
Q3
$777K Buy
+27,712
New +$951K 0.08% 395
2022
Q4
Sell
-8,371
Closed -$206K 1027
2022
Q3
$206K Sell
8,371
-24,343
-74% -$803K 0.02% 815
2022
Q2
$1.05M Buy
+32,714
New +$1.2M 0.14% 214
2022
Q1
Sell
-29,064
Closed -$975K 745
2021
Q4
$975K Buy
+29,064
New +$905K 0.23% 121
2021
Q2
Sell
-8,178
Closed -$227K 646
2021
Q1
$227K Buy
+8,178
New +$218K 0.06% 514

Other funds holding CC

Y-Intercept (HK)'s CC Position: Q2 2026 in Review

Y-Intercept (HK) increased its Chemours (CC) stake by 122% in Q2 2026, buying an estimated $1.55M and bringing the position to 123,478 shares worth $2.53M. The position accounts for 0.05% of the portfolio, ranked #570.

Y-Intercept (HK) first reported a position in CC in Q1 2021 and has held it in 12 quarters since. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Y-Intercept (HK) held 123,478 shares of Chemours worth $2.53M as of Q2 2026.
  • Y-Intercept (HK) bought 67,886 Chemours shares in Q2 2026, an estimated $1.55M.
  • Chemours made up 0.05% of Y-Intercept (HK)'s portfolio in Q2 2026, its #570 holding.
  • Y-Intercept (HK) first reported a position in Chemours in Q1 2021 and has held it in 12 quarters since.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.